Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples